This document is an authorization form for the Repatha Ready program, which involves patient consent for Amgen to use and disclose personal and health information for program administration and promotional purposes. It includes privacy notices, patient and prescriber information, and consent for contact methods.
documents/EFTA00298075.pdf
{}